TY - JOUR T1 - Update of recommendations on the use of palivizumab as prophylaxis in RSV infections JO - Anales de PediatrĂ­a (English Edition) T2 - AU - Figueras Aloy,J. AU - Carbonell Estrany,X. SN - 23412879 M3 - 10.1016/j.anpede.2014.10.007 DO - 10.1016/j.anpede.2014.10.007 UR - https://www.analesdepediatria.org/en-update-recommendations-on-use-palivizumab-articulo-S234128791500037X AB - The Standards Committee of the Spanish Neonatology Society (SENeo) considers that the new document from the American Academy of Pediatrics, including recommendations for palivizumab use to prevent serious infections produced by the Respiratory Syncytial Virus (RSV), provides no new scientific evidence which would justify the modification of the current recommendations of the SENeo. However, some adjustments to the criteria of the existing recommendations are proposed to reduce the cost of the drug by its correct and judicious management. ER -